Handelsavisen
prelaunch
Companies ›300109.SZ
30
300109.SZ — Shenzhen Stock Exchange Unclassified

Boai NKY Medical Holdings Ltd

¥19,23
Open in Charts → Attach watcher ⌖
— —
CNY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
11,1B CNY
P/E
—
EV / Rev
—
Div yield
1,16 %
Op margin
20,2 %
ROE
5,2 %
Net margin
16,1 %
Debt / equity
0,10
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

Boai NKY Medical Holdings Ltd operates in the medical sector, generating revenue through undisclosed specific products or services as detailed segment data is absent.

Business. Boai NKY Medical Holdings Ltd operates in the medical sector, generating revenue through undisclosed specific products or services as detailed segment data is absent.

Classification20 %
SectorUnclassified
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
5,2 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 300109.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 300109.SZ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Boai NKY Medical Holdings Ltd operates in the medical sector, generating revenue through undisclosed specific products or services as detailed segment data is absent.

    Classification20 %
    SectorUnclassified
    AI synthesis
    GENERATED

    Boai NKY Medical Holdings Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.1 and a current ratio of 2.95, indicating strong short-term liquidity coverage. The company holds total equity of 3.68 billion CNY against total liabilities of 683.57 million CNY. Despite positive operating cash flow of 338.11 million CNY, free cash flow is negative at -57.16 million CNY due to capital expenditures of 220.42 million CNY. The risk assessment flags medium liquidity risk and notes that net cash is negative after subtracting total debt, suggesting reliance on external financing or cash reserves for ongoing operations.

    Profitability metrics show a return on equity of 5.16% and a return on assets of 4.35%, which are modest returns relative to the capital employed. The company generated a net income of 190.09 million CNY on revenue of 1.18 billion CNY, resulting in a net margin of approximately 16.1%. Operating income stands at 237.43 million CNY, reflecting an operating margin of roughly 20.2%. Without cohort median data for direct comparison, these returns appear stable but not exceptional, consistent with a mature or capital-intensive medical business model.

    Segment and geographic revenue breakdowns are not provided in the available data, preventing analysis of revenue concentration or regional exposure. The absence of this information limits the ability to assess diversification risks or specific market dependencies.

    Growth trajectory analysis is constrained by the lack of historical period data in the input. Only the latest normalized period's financials are available, showing revenue of 1.18 billion CNY. Without multi-year trends, it is not possible to determine the company's growth rate or consistency over time.

    Risk factors include medium liquidity risk and low dilution risk. The key flag indicates that net cash is negative after subtracting total debt, which may impact financial flexibility. The low dilution risk suggests that share count stability is likely, with basic and diluted shares outstanding both at 576.86 million.

    Recent events, filings, news, and transcript observations are not provided in the input data. Therefore, no recent developments can be cited to inform the current analysis.

    Key takeaways
    • Strong liquidity position with a current ratio of 2.95 and low debt-to-equity of 0.1.
    • Negative free cash flow of -57.16 million CNY driven by significant capital expenditures.
    • Modest profitability with ROE of 5.16% and ROA of 4.35%.
    • Low dilution risk with stable share count.
    • Medium liquidity risk flagged due to negative net cash after debt subtraction.
    • Lack of historical and segment data limits comprehensive growth and diversification analysis.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥19,23
    Market cap
    ¥8.19B
    Enterprise valueⓘ
    ¥8.54B
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    25.3x
    P / Bⓘ
    2.2x
    P / Tangible bookⓘ
    2.2x
    Tangible book
    ¥3.68B
    Net cashⓘ
    -¥353.0M
    Current ratioⓘ
    3.0
    Debt / equityⓘ
    0.1
    ROAⓘ
    4.3%
    ROEⓘ
    5.2%
    Cash conversionⓘ
    178.0%
    CapEx / revenueⓘ
    -18.7%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin20,2 %Above P75
    Net Margin16,1 %Above P75
    ROE5,2 %Below median
    Capex / Rev-18,7 %Bottom quartile
    D/E0,10Above median
    Cash Conv1,78Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Ev To Revenue
      enterprise_value / revenue
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Return On Assets
      net_income / total_assets
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • Boai NKY Medical Holdings Ltd Market data — financials · 2026-07-09

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    300109.SZCanonical
    Shenzhen Stock Exchange · CNY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage